Save the date for the Florida Society of Pathologists Summer Pathology Conference taking place July 12-14 at the Ritz-Carlton Hotel in Fort Lauderdale, Florida.
The conference will feature innovative topics in pathology and interesting case presentations related to topics featured throughout the conference.
In addition to the educational offerings, attendees will have an opportunity to connect with colleagues and interact with industry leaders in the field of pathology during exhibit hall social functions.
Make plans to arrive on Friday, July 12 in the afternoon to check in early and enjoy the hotel at your leisure before the conference kicks off on Saturday, July 13
|Abstract Poster Submission #1|
|Disclosure of Funding Support|
|Choose one of the following Topics|
Richard R. Gammon, MD
Topic: Blood Banking
Dina R. Mody, MD
Medical Director, Cytopathology
Department of Pathology and Genomic Medicine
The Ibrahim Ramzy chair in Pathology
Houston Methodist Hospital
Professor of Pathology and Laboratory Medicine
Weill College Medicine
Topic: Cytology in conjunction with surgical pathology
Mehrdad Nadji, MD
Professor and Vice Chair
Department of Pathology
University of Miami Miller School of Medicine
Topic: IHC and Molecular Biomarkers
Rish K. Pai, MD, PhD
Professor of Laboratory Medicine and Pathology
Topic: Gastrointestinal Pathology and Medical Liver
Artur E. Rangel Filho, MD, PhD
Medical Director, Clinical and Molecular Pathology
Memorial Healthcare System
Pathology Consultants of South Broward
Topic: Basics of Molecular Diagnostics for the Everyday Practicing Pathologist
The Ritz Carlton Fort Lauderdale is a premier beachfront location offering guests remarkable amenities including an infinity pool overlooking the ocean; direct access to the beach with towel and chair service, a luxurious 8,500 square foot spa, and state of the art room accommodations all equipped with balconies to admire the views of Fort Lauderdale. From discovering the boutiques of Las Olas Boulevard to exploring the canals of the Florida Intracoastal Waterway, Fort Lauderdale is a destination that will surprise and delight travelers.
The FSP has a special discounted room rate of $199/night plus a $20/night resort fee. The group rate is available until June 17, 2019 or until the room block is filled. We recommend that you make your reservation early, the room block will sell out.
The following amenities and services are included in the resort fee:
The Ritz-Carlton is sold out on Saturday night. There are several hotels within walking distance of the Ritz Carlton:
W Fort Lauderdale - $242/night plus taxes and fees
.4 miles from Ritz-Carlton
Westin Fort Lauderdale Beach Resort - $169/night plus taxes and fees
.4 miles from Ritz-Carlton
NOTE: If you'd like to be placed on a waiting list if a room becomes available, please email Kasey Cleary at email@example.com with your name and desired hotel stay dates.
Registration will open on Friday, July 12 from 3:00–6:00 PM. Breakfast will be provided on Saturday, July 13 in the exhibit hall at 7:00 AM, and the ﬁrst session will begin at 8:00 AM. Book your hotel for Friday, July 12 to take full advantage of the FSP Summer Anatomic Pathology Conference.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Florida Medical Association and the Florida Society of Pathologists. The Florida Medical Association is accredited by the ACCME to provide continuing medical education for physicians.
The Florida Medical Association designates this live activity for a maximum of 10.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component enables the participant to earn up to 9.5 Self-Assessment Module (SAMs) credits in the American Board of Pathology’s (ABPath) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to the ACCME for the purpose of granting ABPath SAMs credit.
CRITERIA FOR SUCCESS
Statements of credit/participation will be awarded based on the participant’s attendance at each session and submission of the activity evaluation form. A statement of credit will be available upon completion of an online evaluation/claimed credit form at www.flpath.org/claimcme. If you have questions about this CME/CE activity, please contact the FSP at 904-309-6261. Credit must be claimed by July 24, 2019.
This activity is designed to meet the needs of practicing physicians, pathologists, and other specialists involved with pathology.
STATEMENT OF NEED
The field of pathology is constantly changing, and many of the most important advances in the field. In the setting of new technology, techniques and advancements in the field, practice gaps are inevitable. As such, pathologists require ongoing educational opportunities to stay current in order to maintain and improve their knowledge and competence in the field.
At the conclusion of this activity, all participants should be able to:
This activity is supported by educational grants from Olympus and Pfizer, Inc.
FACULTY AND PLANNER DISCLOSURES
|Name of Individual||Individual’s Role in Activity||Name of Commercial Interest||Nature/Type of Relationship|
|Antonio Martinez, M.D.||Planner||None||N/A|
|Qihui Jim Zhai, MD||Planner||None||N/A|
|Rish K. Pai, MD, PhD||Faculty||None||N/A|
|Dina R. Mody, MD||Faculty||None||N/A|
|Mehrdad Nadji, MD||Faculty||None||N/A|
|Richard R. Gammon, MD||Faculty||None||N/A|
|Artur E. De Rangel Filho, MD, PhD||Faculty||None||N/A|
DISCLOSURE OF THE FLORIDA MEDICAL ASSOCIATION
It is the policy of the Florida Medical Association (FMA) to ensure independence, objectivity and scientific rigor in all approved CME content. CME faculty must present evidence-based data, clarify off-label product use and disclose all relevant financial relationships to theaudience. The ideas and opinions expressed during jointly provided events do not necessarily reflect those of the FMA, and the FMA’s approval of course content for AMA PRA Category 1 Credits™. does not constitute an endorsement of the ideas, positions or statements contained therein. Every effort has been made to ensure that all information provided by the joint provider is accurate and current. However, FMA does not accept responsibility for errors or omissions and accepts no liability for any resulting loss or damage. Attendees agree to participate in this CME activity with full knowledge and awareness that they waive any claim they may have against the FMA for injury or other damage that may result in any way from their participation in this activity
We invite you to participate as a sponsor and exhibitor in the Florida Society of Pathologists Summer Pathology Conference taking place on July 13-14 in Ft. Lauderdale, Florida. Interact and showcase your products and services with approximately 150 pathologists.
We have added some new and exciting sponsorship opportunities and look forward to working wtih you to confirm your participation in our event.
For more information on exhibiting or sponsoring please call 904-309-6204 or email firstname.lastname@example.org
The following information is important exhibitor resources. Please review this information in advance of the meeting to ensure a successful meeting.
Electricity must be ordered in advance of the meeting through PSAV at the Ritz Carlton Hotel. To confirm electricity download and complete the below form and email directly to PSAV as indicated on the form.
If shipping boxes direct to the hotel, please label boxes with the exact information provided below to ensure proper delivery:FAO: (Michelle Neier) 1 North Fort Lauderdale, Beach Blvd. Fort Lauderdale, Florida 33304 Florida Society of Pathologists – Exhibitor: COMPANY NAME (July 11-14, 2019) Hold For: (EXHIBITOR CONTACT NAME)
Any materials to be sent to Hotel may arrive no earlier than three (3) days in advance of the setup day of the meeting on Friday, July 12. If storage exceeds 3 days, a storage fee will be added.
If shipping boxes to the hotel, exhibitor MUST complete the credit card authorization form provided by the hotel below to ensure exhibitor can collect company boxes upon arrival. Email completed form to Ritz Carlton Hotel Conference Concierge, Chrystal, Chrystal.Hidalgo@ritzcarlton.com
Please download the exhibit hall hours for more information on setup, hall hours and tear down.
Sponsored Lunch Symposium Details
Title of Activity:
The TRK to Tumor-Agnostic Care in Solid Tumors: A Pathology-Focused Guide to the Clinical Role of TRK Fusions in Personalizing Cancer Therapy
Date of Activity:
Saturday, July 13, 2019 at 12:45 PM – 1:45 PM
Anna F. Farago, MD, PhD
Assistant in Medicine
Massachusetts General Hospital
Assistant Professor of Medicine
Harvard Medical School
With the approval of the first ‘tumor agnostic’ strategy directed against NTRK gene fusion positive cancers, there’s an acute need for clinical professionals to understand how best to capture gene fusions and integrate appropriate TRK inhibitors into cancer care. This curriculum will explore how pathologists and oncologists can collaborate to apply precision oncology treatment tools in adult and pediatric patients across a wide range of TRK fusion-positive solid tumors. Experts will discuss the rationale for molecular testing for TRK fusions in a range of cancer settings, including head and neck cancer, GI cancers, breast cancer, and lung cancer, among others, as well as which patients may be candidates for treatment with TRK inhibitors. Other topics will include a guide to selecting and interpreting results of diagnostic testing techniques for confirming the presence of TRK fusions, as well as strategies for using this diagnostic information when making clinical decisions.
Educational Grant supported by:
Bayer and Loxo Oncology
To reserve your seat for this lunch symposium please email email@example.com
Sponsored Dinner Innovation Lab
Title of Activity:
Pathology Leadership in Biomarker Testing: Pre-Analytical Phase
Date of Activity:
Saturday, July 13, 2019 at 7:00 PM - 8:00 PM
John Longshore, PhD
Director of Molecular Pathology Lab
Carolinas Pathology Group
Charlotte, North Carolina
This program will provide an overview of practical considerations for the pre-analytical phase, focusing on the aspects that pathologists may impact along the biomarker testing journey. The presentation will utilize a patient case throughout the program to highlight key steps in the pre-analytical phase, specifically diving deeper into sufficiency of tissue acquired, tissue handling and processing, and the multi-disciplinary team approach.
To pre-register, please RSVP at 1-866-326-7600 from 8:30 AM – 5:00 PM EST, Monday-Friday using meeting ID 190713-NON-47863.
Saturday, July 13 │6:00-7:00 pm
Location: Grand Ballroom at the Ritz Carlton Hotel
Everyone is welcome and encouraged to attend this opening night reception, which will feature beer, wine and hors d’oeuvres. At the welcome reception we will be honoring all new members to the Society. We hope you will participate ‒ this is the perfect chance to get to know new colleagues and visit with our supporters!
APS Medical Billing is a premier billing company that provides expert billing and practice management solutions to practices nationwide. Some of the services provided include expert ICD-10 and CPT coding, contract management, and comprehensive charge capture systems to ensure its client’s financial success.
Biocartis is an innovative molecular testing company providing next generation solutions aimed to researchers in the oncology field. Biocartis’ proprietary Idylla™ platform is a fully automated sample-to-result, real-time PCR system that offers accurate, highly reliable molecular information from a variety of biological samples in virtually any laboratory setting. Today, Biocartis offers assays for EGFR, KRAS, NRAS, BRAF, and MSI biomarkers and is developing a rapidly expanding menu. Our global headquarters are in Belgium with a U.S. office located in Jersey City, NJ. Globally, we have a presence in 70 countries and there are over 940 Idylla™ systems in place.
Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious diseases. We are focused on helping patients in disease areas including oncology, cardiovascular, immunoscience and fibrosis. Each day, our employees work together for patients - it drives everything we do.
Boca Biolistics focuses on IVD diagnostics along with CRO services, diagnostic testing, biobanking, and commercial biobank storage to a wide range of companies. Our reference lab is ISO 13485/ CAP certified. We are notorious among our clientele for the personalized customer service and rapid turnover time that we provide. Boca Biolistics company goal is to advance the future of the diagnostic research industry. All organization capabilities are utilized for research purposes only.
Caris Life Sciences® is a leading innovator in molecular science focused on fulfilling the promise of precision medicine. Caris Molecular Intelligence®, the company's Comprehensive Genomic Profiling Plus (CGP+) molecular testing service, assesses DNA, RNA and proteins to reveal a molecular blueprint to guide more precise and personalized treatment decisions.
Cleveland Clinic Laboratories is dedicated to providing high-quality, clinically impactful pathology and laboratory diagnostic services combined with readily available consultation from experienced pathologists and laboratory scientists.
CSI Laboratories is an industry-leading cancer diagnostics laboratory that has been providing personalized cancer testing services to support pathologists and the cancer community for more than 20 years. With support from our nationally recognized medical team, we proudly offer some of the most extensive test menus available for full-service and tech-only testing services. Our laboratories in Alpharetta, Georgia and Jupiter, Florida provide rapid turnaround and 24/7 support to pathologists in Florida, Georgia and across the U.S. When you need FISH, Flow, Histology, Cytogenic or Molecular testing, turn to CSI for the most accurate results.
The goal of Discern Management Group is to help you maximize revenue and minimize concerns. Discern provides an overall understanding of the business side of your practice. Since Discern is not affiliated with a billing service, our independence allows an unbiased review of your entire practice. Discern will partner with the physician group to maximize income for services already being performed and help stop the trend of decreasing annual revenue. Partnering with Discern gives you the peace of mind that your practice is reaching its maximum potential, allowing you to focus your efforts on patient care and medicine.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, and deliver better care.
We are a comprehensive genomic profiling company.
Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. We are among the world's leading biotech companies, with multiple products on the market and a promising development pipeline.
General Data Healthcare understands that each tissue specimen your lab processes has a life story behind it. Your critical mission is to ensure your lab has the best instruments, technology, and resources in order to deliver optimal clinical outcomes along with the best possible care. Our innovative and comprehensive histology lab solutions provide everything your lab needs for increased efficiency, reliability, safety, and accurate results. Complete laboratory solutions mean that your lab can eliminate specimen misidentification, streamline lab workflow, increase productivity and throughput, and enhance overall patient safety. Stop by our booth and discover how we can help!
GenPath is a CAP and CLIA accredited national laboratory whose expertise in cancer diagnostics is unmatched. GenPath continually invests in new technologies for optimal patient management, such as OnkoSight tumor sequencing, hereditary cancer testing, and the 4Kscore Test. GenPath is a division of BioReference Laboratories, an OPKO Health Company.
We develop and commercialize molecular diagnostic tests for thyroid and pancreas disease.
Innovative Pathology-Oncology specialty reference lab and diagnostic company.
MedReceivables is a full service outsourcing medical billing company for the hospital based physician, specializing in the pathology arena.
Since 2002, Medusind has provided revenue cycle management, coding, credentialing and billing services to healthcare organizations nationwide. Along with our MedClarity billing platform, our billing experts and certified coders become an integral part of your team ensuring that you remain compliant and profitable in this ever-changing healthcare environment. We provide customized reports to meet your specific needs and offer deep insight into all aspects of your revenue cycle. Our 2,500 employees, 11 operation centers and unmatched expertise ensures that our capabilities and responsiveness are second to none.
Med Pro distributes medical equipment critical in pathological study, diagnosis, and treatment. We will be presenting Well Tube Incubators and Moisture Titrators with LED anti-bacterial and anti-fungal capability.
For more than a century, Merck has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Today, Merck continues be at the forefront of research to deliver innovative health solutions and advance the prevention and treatment of diseases that threaten people and animals around the world.
MSN combines industry leading technology with unmatched experience and outstanding customer service to deliver superior billing, practice management and business intelligence services. Its Clients benefit from continual, proactive communication which develops a truly efficient and effective long-term relationship.
Neogenomics specializes in cancer genetic testing and information services with the most comprehensive oncology-focused testing menus globally to diagnose and treat cancer. NeoGenomics operates CLIA certified laboratories serving the needs of pathologists, oncologists, academic centers, hospital systems, Pharma, and managed care organizations.
Professional Casualty Corporation aims to provide physicians with the comprehensive, professional liability coverage they need while offering competitive rates in a constantly evolving world of medical malpractice insurance. PCC holds itself to the highest standards by treating all inquiries with the same care and prompt responses. Professional Casualty Corporation is among Florida’s most prominent medical malpractice coverage brokers. In an effort to make sure physicians receive proper protection, PCC persistently evaluates companies based on their current policies, premiums and claims history. All medical specialties and entities are eligible for coverage with PCC regardless of physicians’ claims histories. In many cases no tail is required when changing carries, physicians may be able to obtain prior acts-inclusive policies. In an ever-changing market, we assure you that Professional Casualty Corporation will always be there to guide you to the best possible coverage.
MLabs is a full-service reference laboratory and part of one of largest health care complexes in the world, Michigan Medicine. With 30+ years of reference laboratory experience, MLabs is CLIA-certified/CAP accredited, committing to delivering the highest quality laboratory results to meet the needs of today’s patients in a cost effective and personalized manner. Our nationally recognized faculty comprise one of the strongest groups of diagnostic pathologists in the world. Consultations and second opinions are provided in all subspecialties. MLabs is a recognized leader for advance molecular diagnostic testing, continuously adding new molecular assays. Expertise Delivered Personally.
Over the last ten years, Vitro Molecular Laboratories has been providing routine esoteric services to academic institutions, Biotechnology companies, community hospitals and major healthcare systems in over 16 states in the US, as well as Canada, Mexico, Venezuela, Dominican Republic, Chile and Brazil. Services include immunohistochemistry, FISH, cytogenetics, flow cytometry, PCR and technical only services in flow cytometry, FISH and IHC. Over the years, We have redefined the concept of anatomic pathology esoteric service offering. We consider service components such as comprehensive esoteric testing menu, fast turnaround time, friendly customer support and competitive fee schedule not the end objective of our services, but the beginning of a much more involved relationship with our clients.
We sell medical books.
FSP Member Login